Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04644796 · ClinicalTrials.gov registry record · Phase 4
A Randomized Trial of Exparel vs Saline in Opioid Reduction of Pain Management Following Lumbar Spine Surgeries.
A Phase 4 study of Lumbar Spine Degeneration, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT04644796 is a Phase 4 study of Lumbar Spine Degeneration that has completed, run by University of Missouri-Columbia. The registered enrollment target is 34 participants, below the 639-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04644796, a Phase 4 study of Lumbar Spine Degeneration, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to establish a relationship between liposomal bupivacaine surgical site injection and postop opioid utilization.
Conditions Studied
Interventions
- DRUG Liposomal bupivacaine
- DRUG saline 0.9%
Study Locations (1)
Missouri
- Missouri Orthopaedic Institute - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2022-06-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04644796
The ClinicalTrials.gov registry entry for NCT04644796 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 639-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (95% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lumbar Spine Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Liposomal bupivacaine is the first listed.
NCT04644796 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04644796 about?
NCT04644796 is a clinical study titled "A Randomized Trial of Exparel vs Saline in Opioid Reduction of Pain Management Following Lumbar Spine Surgeries.". The purpose of this study is to establish a relationship between liposomal bupivacaine surgical site injection and postop opioid utilization.
What is the current status of trial NCT04644796?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2021-02-10. Estimated completion is 2022-06-13.
What conditions does trial NCT04644796 study?
This clinical trial studies the following conditions: Lumbar Spine Degeneration.
What interventions are being tested in trial NCT04644796?
The interventions under investigation include: Liposomal bupivacaine (DRUG), saline 0.9% (DRUG).
Who is sponsoring clinical trial NCT04644796?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04644796 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lumbar Spine Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults
RECRUITING
-
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
RECRUITING · NA
-
3Spine Lumbar Fusion Real World Evidence Study
ACTIVE NOT RECRUITING
-
MOTUS Total Joint Replacement Investigational Device Exemption Study
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.